Fig. 5From: Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patientsPlasma concentration of RA after ingestion of various doses of RA on day 1 of treatment [50, 57]. Dots show the pharmacokinetic data, while lines indicate the simulation results by a two-compartment pharmacokinetic modelBack to article page